Ｂ型肝炎抗体 - Novartis Age

Title:

Ｂ型肝炎抗体

Document Type and Number:

Japanese Patent JP7490574

Kind Code:

B2

Abstract:

The present invention relates to anti-HBsAg antibodies, antibody fragments, and their uses for the prevention and treatment of hepatitis B virus infection and associated diseases.

More Like This:

JP2017538445	Antibodies that specifically bind to PRES1 of hepatitis B virus and its uses
WO/2013/022848	ANTI-POLYUBIQUITIN ANTIBODIES AND METHODS OF USE
WO/1990/011302	ANTIBODY AND T CELL RECOGNITION SITES ON GLYCOPROTEINS

Inventors:

Ewart, Stephane
Holdorf, Megan Marie
Tradje, Elizabeth

Application Number:

JP2020564748A

Publication Date:

May 27, 2024

Filing Date:

May 30, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Novartis Age

International Classes:

C07K16/08; A61K39/395; A61K45/00; A61P1/16; A61P31/20; A61P43/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/13; C12N15/63; G01N33/53; G01N33/536

Domestic Patent References:

JP2016504015A
JP2002502222A

Foreign References:

WO2017060504A1
WO2017059813A1
US20160326233

Attorney, Agent or Firm:

Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Noriki Mihashi
Yasuhito Suzuki

Previous Patent: Corrosion-resistant permanent magnet and intravascular blood pump including said magnet

Next Patent: Dead reckoning and latency improvements in 3D game streaming scenarios